Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Axetine 250 mg powder for solution for injection or infusion.
Axetine 750 mg powder for solution for injection or infusion.
Axetine 1.50 g powder for solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection or infusion. White or almost white to yellowish powder. |
Each vial contains 250mg or 750mg or 1.5g cefuroxime as cefuroxime sodium.
| Axetine strength | Amount of sodium per vial |
|---|---|
| 250 mg | 13.55 mg (0.589 mmol) |
| 750 mg | 40.65 mg (1.77 mmol) |
| 1.5 g | 81.45 mg(3.54 mmol) |
| Active Ingredient | Description | |
|---|---|---|
| Cefuroxime |
Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. |
| List of Excipients |
|---|
|
None. |
Axetine 250mg powder for solution for injection or infusion:
Type I clear glass vials having a nominal capacity of 10ml that are sealed with a 20mm bromobutyl rubber stopper and an aluminium cap.
Axetine 750mg powder for solution for injection or infusion:
Type I clear glass vials having a nominal capacity of 15ml that are sealed with a 20mm bromobutyl rubber stopper and an aluminium cap.
Axetine 1.5g powder for solution for injection or infusion:
Type I clear glass vials having a nominal capacity of 15ml that are sealed with a 20mm bromobutyl rubber stopper and an aluminium cap.
Boxes of 1, 10, 50 or 100 vials.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Axetine 250 mg: 13413
Axetine 750 mg: 13412
Axetine 1.5 g: 14882
Axetine 250 mg: 26.06.1991 / 29.10.2012
Axetine 750 mg: 25.06.1991 / 29.10.2012
Axetine 1.5 g: 14.07.1994 / 11.10.2010
| Drug | Countries | |
|---|---|---|
| AXETINE | Cyprus, Estonia, Hong Kong, Croatia, Lithuania, Malta, Romania, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
